The MAP kinase 5—extracellular signal-regulated kinase 5 (MEK5-ERK5) pathway is a constituent of the MAPK pathway, and it has emerged as a potential carcinogenesis promoting signalling pathway in several cancers, including breast cancers, and is thus considered a promising target for therapeutic intervention [20–22]. The gene discussed is MAP2K5; the disease is breast cancer.